Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 13942-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#13942-1-AP, RRID:AB_2299394
- Product name
- PGM2L1 antibody
- Antibody type
- Polyclonal
- Description
- PGM2L1 antibody (Cat. #13942-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IHC, IP, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Integrative Single-Cell and Bulk RNA Sequencing Identifies a Glycolysis-Related Prognostic Signature for Predicting Prognosis in Pancreatic Cancer.
Cancer-associated fibroblasts secrete CSF3 to promote TNBC progression via enhancing PGM2L1-dependent glycolysis reprogramming.
Glucose-1,6-bisphosphate: A new gatekeeper of cerebral mitochondrial pyruvate uptake.
Protein kinase N1 deficiency results in upregulation of cerebral energy metabolism and is highly protective in in vivo and in vitro stroke models.
Wu N, Zhou C, Yan X, Liu Z, Jiang R, Luo Y, Jiang P, Mu Y, Xiao S, Huang X, Zhou Y, Sun D, Jin Y
International journal of molecular sciences 2025 May 26;26(11)
International journal of molecular sciences 2025 May 26;26(11)
Cancer-associated fibroblasts secrete CSF3 to promote TNBC progression via enhancing PGM2L1-dependent glycolysis reprogramming.
Qin W, Chen B, Li X, Zhao W, Wang L, Zhang N, Wang X, Luo D, Liang Y, Li Y, Chen X, Chen T, Yang Q
Cell death & disease 2025 Apr 4;16(1):249
Cell death & disease 2025 Apr 4;16(1):249
Glucose-1,6-bisphosphate: A new gatekeeper of cerebral mitochondrial pyruvate uptake.
Safari MS, Woerl P, Garmsiri C, Weber D, Kwiatkowski M, Hotze M, Kuenkel L, Lang L, Erlacher M, Gelpi E, Hainfellner JA, Baier G, Baier-Bitterlich G, Zur Nedden S
Molecular metabolism 2024 Oct;88:102018
Molecular metabolism 2024 Oct;88:102018
Protein kinase N1 deficiency results in upregulation of cerebral energy metabolism and is highly protective in in vivo and in vitro stroke models.
Zur Nedden S, Safari MS, Weber D, Kuenkel L, Garmsiri C, Lang L, Orset C, Freret T, Haelewyn B, Hotze M, Kwiatkowski M, Sarg B, Faserl K, Savic D, Skvortsova II, Krogsdam A, Carollo S, Trajanoski Z, Oberacher H, Zlotek D, Ostermaier F, Cameron A, Baier G, Baier-Bitterlich G
Metabolism: clinical and experimental 2024 Dec;161:156039
Metabolism: clinical and experimental 2024 Dec;161:156039
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- mouse skeletal muscle tissue were subjected to SDS PAGE followed by western blot with 13942-1-AP(PGM2L1 antibody) at dilution of 1:800
- Sample type
- tissue
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemical of paraffin-embedded human gliomas using 13942-1-AP(PGM2L1 antibody) at dilution of 1:50 (under 10x lens)
- Sample type
- tissue
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The PGM2L1 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human PGM2L1. This antibody recognizes human, mouse, rat antigen. The PGM2L1 antibody has been validated for the following applications: ELISA, WB, IHC analysis.
